Hassle-Free Closures: How Patent Monetize Manages Everything from Listing to Legal Closure

Pharmaceutical formulation development traditionally requires extensive laboratory experimentation to determine the appropriate combination and concentration of active pharmaceutical ingredients, excipients, and processing parameters. This trial-and-error approach can be time-consuming, costly, and resource-intensive. Small changes in formulation parameters may significantly affect critical attributes such as stability, dissolution, bioavailability, dosage uniformity, and manufacturability.

Existing formulation development processes also rely heavily on manual data analysis and the experience of formulation scientists, making it difficult to efficiently evaluate a large number of possible formulation combinations. Inadequate optimization may result in repeated experiments, increased development costs, inconsistent formulation performance, and delays in bringing pharmaceutical products to market.

The present invention provides an automated system for pharmaceutical formulation optimization that systematically analyzes formulation variables and identifies an optimized combination of pharmaceutical ingredients and processing parameters.

The system receives formulation-related inputs, including active pharmaceutical ingredients, excipients, concentrations, processing conditions, and target product characteristics. An optimization engine processes these parameters using statistical models, machine-learning algorithms, or other computational techniques to evaluate multiple possible formulation combinations.

Based on predefined performance criteria such as stability, dissolution, bioavailability, hhhdosage uniformity, release profile, and manufacturability, the system identifies the most suitable formulation parameters and generates optimization recommendations.

Yes, a major gap exists.

Despite existing pharmaceutical formulation software, statistical optimization tools, and computer-aided drug development systems, there remains a gap in fully automated, end-to-end formulation optimization. Many existing approaches require significant manual intervention by formulation scientists to select variables, define experimental combinations, interpret results, and determine the final formulation.

The proposed invention addresses this gap by integrating formulation data acquisition, parameter evaluation, predictive analysis, optimization, and formulation recommendation within a unified automated system. This enables the system to evaluate multiple formulation variables simultaneously and identify optimized combinations based on predefined pharmaceutical performance criteria.